Shares of Merus N.V. (NASDAQ:MRUS) have received a consensus rating of “Hold” from the six brokerages that are covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating on the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $30.25.

A number of research firms have commented on MRUS. Royal Bank Of Canada began coverage on shares of Merus N.V. in a research report on Thursday, September 14th. They set an “outperform” rating and a $28.00 target price on the stock. Zacks Investment Research downgraded shares of Merus N.V. from a “hold” rating to a “sell” rating in a research report on Wednesday, October 11th. ValuEngine downgraded shares of Merus N.V. from a “hold” rating to a “sell” rating in a research report on Monday, October 2nd. Finally, Jefferies Group LLC reissued a “buy” rating and set a $30.00 target price on shares of Merus N.V. in a research report on Thursday, October 26th.

ILLEGAL ACTIVITY WARNING: This piece of content was first published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/11/03/merus-n-v-mrus-receives-consensus-recommendation-of-hold-from-brokerages.html.

An institutional investor recently bought a new position in Merus N.V. stock. Renaissance Technologies LLC bought a new position in Merus N.V. (NASDAQ:MRUS) in the first quarter, according to its most recent filing with the SEC. The firm bought 22,500 shares of the biotechnology company’s stock, valued at approximately $549,000. Renaissance Technologies LLC owned approximately 0.14% of Merus N.V. as of its most recent SEC filing. Institutional investors and hedge funds own 31.53% of the company’s stock.

About Merus N.V.

Receive News & Ratings for Merus N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merus N.V. and related companies with MarketBeat.com's FREE daily email newsletter.